BRAF and colorectal carcinoma: In CRC, CGP plays a crucial role in evaluating key biomarkers such as RAS, BRAF, HER2, MSI, TMB, RET fusions, and NTRK fusions, which are essential for selecting molecularly targeted therapies and ICIs.